Detalles de la búsqueda
1.
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
J Cancer Res Clin Oncol
; 147(8): 2349-2359, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33433659
2.
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
J Cancer Res Clin Oncol
; 143(10): 2049-2058, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28534173
3.
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
J Cancer Res Clin Oncol
; 141(11): 2013-22, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25976868
4.
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
J Cancer Res Clin Oncol
; 140(11): 1947-56, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942335
Resultados
1 -
4
de 4
1
Próxima >
>>